Skip to content

Clinical trials

Phase 1/2 Melanoma trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Melanoma Phase: Phase 1/2 Country / region: Germany Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20032
20041
20053
20061
20071
20101
20133
20154
20163
20171
20183
20192
20213
20224
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Recruiting5
Terminated5
Active, not recruiting4
Unknown status3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb4
Novartis Pharmaceuticals4
University Hospital Erlangen3
University Hospital Tuebingen3
4SC AG1
Amgen1
Anaveon AG1
Array Biopharma, now a wholly owned subsidiary of Pfizer1
BioInvent International AB1
BioNTech SE1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Melanoma39
Neoplasms8
Carcinoma, Non-Small-Cell Lung7
Neoplasm Metastasis5
Uveal Melanoma5
Squamous Cell Carcinoma of Head and Neck4
Colorectal Neoplasms3
Ovarian Neoplasms3
Pancreatic Neoplasms3
Recurrence3

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.